Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2026-01-04 @ 4:31 PM
Study NCT ID:
NCT00095394
Status:
COMPLETED
Last Update Posted:
2011-04-15
First Post:
2004-11-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension
Sponsor:
Bristol-Myers Squibb
Organization: